Lidocaine-prilocaine patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response
- 1 June 2000
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 136 (6) , 789-794
- https://doi.org/10.1016/s0022-3476(00)64169-0
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Topical application of lidocaine-prilocaine (EMLA) cream reduces the pain of intramuscular infiltration of saline solutionThe Journal of Pediatrics, 1996
- Effect of Inactivated Poliovirus Vaccine on the Antibody Response to Bordetella pertussis Antigens When Combined with Diphtheria-Pertussis-Tetanus VaccineClinical Infectious Diseases, 1996
- Measles and rubella antibody response after measles-mumps-rubella vaccination in children with afebrile upper respiratory tract infectionThe Journal of Pediatrics, 1995
- A revised measure of acute pain in infantsJournal of Pain and Symptom Management, 1995
- Immune Responses to Pertussis Vaccines Concurrently Administered with Viral VaccinesAnnals of the New York Academy of Sciences, 1995
- Use of lidocaine-prilocaine cream for vaccination pain in infantsThe Journal of Pediatrics, 1994
- Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccinesThe Journal of Pediatrics, 1992
- A prospective survey of reactions to blood tests by children and adolescentsPain, 1990
- Reduction of pain at venous cannulation in children with a eu tec tic mixture of lidocaine and prilocaine (EMLA® cream): comparison with placebo cream and no local premedicationActa Anaesthesiologica Scandinavica, 1987
- A comparison of the antibacterial properties of six local analgesic agentsAnaesthesia, 1977